Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 21;11(35):5565-7.
doi: 10.3748/wjg.v11.i35.5565.

Detection of HBsAg, HBcAg, and HBV DNA in ovarian tissues from patients with HBV infection

Affiliations

Detection of HBsAg, HBcAg, and HBV DNA in ovarian tissues from patients with HBV infection

Li-Zhang Chen et al. World J Gastroenterol. .

Abstract

Aim: To investigate the presence of HBsAg, HBcAg, and HBV DNA in ovarian tissues from patients with HBV infection.

Methods: HBsAg and HBcAg were examined in ovarian biopsy tissues from 26 patients with HBV infection by immunocytochemistry, and HBV DNA was detected in ovarian tissues by PCR.

Results: HBsAg and HBcAg were present with the same positive rate of 34.6% (9/26). The total positive rate was 46.2% (12/26). HBsAg and HBcAg were positive in 6 (23.1%) of the 26 patients. Brown positive particles were diffusely distributed in ovarian cells. The positive rate of HBV DNA was 58.3% (7/12).

Conclusion: HBsAg, HBcAg, and HBV DNA can be detected in ovarian tissues from patients with HBV infection. The presence of HBsAg and HBcAg in ovarian tissues does not correlate with the HBV markers in serum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Positive HBsAg (A) expression and positive HBcAg (B) expression in ovarian tissue and negative control (C and D).
Figure 2
Figure 2
Detection of HBV DNA in ovarian tissue by PCR. M: DNA marker; lanes 1, 3, 4 and 5: positive samples; lane 6: negative control; lane 7: positive control.

Similar articles

Cited by

References

    1. Lansang MA. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut. 1996;38 Suppl 2:S43–S47. - PMC - PubMed
    1. Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, Denis F, Mar ID. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal) Lancet. 1981;1:289–292. - PubMed
    1. Hosoda K, Omata M, Uchiumi K, Imazeki F, Yokosuka O, Ito Y, Okuda K, Ohto M. Extrahepatic replication of duck hepatitis B virus: more than expected. Hepatology. 1990;11:44–48. - PubMed
    1. Chen LB, Chen PL, Wang GL, Song XT, Li YF, Liu CY, Jia KM. Ultrastructural study on extrahepatic infection of duck hepatitis B virus in ducks. Chin Med J (Engl) 1992;105:212–216. - PubMed
    1. Lin CY. Hepatitis B virus deoxyribonucleic acid in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nephropathy patients. Nephron. 1993;63:58–64. - PubMed